NDC 67296-2063 – Buprenorphine and Naloxone

Buprenorphine Hydrochloride 2 mg/1; Naloxone Hydrochloride Dihydrate .5 mg/1 · Film · Buccal, Sublingual

Human Prescription Drug DEA schedule CIII

Product NDC67296-2063

Product details

Brand name
Buprenorphine and Naloxone
Generic name
Buprenorphine and Naloxone
Labeler
Redpharm Drug
Dosage form
Film
Route
Buccal, Sublingual
Marketing category
ANDA · ANDA211785
Marketed since
April 17, 2020
Listing expires
December 31, 2027
Pharmacologic class
Opioid Antagonist; Partial Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for Buprenorphine and Naloxone →

Package NDC codes (2)

Package NDCDescriptionSince
67296-2063-330 POUCH in 1 CARTON (67296-2063-3) / 1 FILM in 1 POUCHApr 17, 2020
67296-2063-66 POUCH in 1 CARTON (67296-2063-6) / 1 FILM in 1 POUCHApr 17, 2020

Other Buprenorphine and Naloxone products